U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
191371191371Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: paclitaxel|Biological: trastuzumab|Drug: erlotinib hydrochloride|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00042809
191372191372Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaTerminatedNo Results AvailableChildhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Promyelocytic Leukemia (M3)|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid LeukemiaDrug: decitabine|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00042796
191373191373Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: D1/3-MAGE-3-His fusion protein|Biological: SB-AS02B adjuvanthttps://ClinicalTrials.gov/show/NCT00042783
191374191374Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With CancerCompletedNo Results AvailableMetastatic Cancer|Pulmonary ComplicationsOther: talc|Procedure: dyspnea managementhttps://ClinicalTrials.gov/show/NCT00042770
191375191375Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical ProstatectomyCompletedNo Results AvailableProstate CancerDietary Supplement: Lycopene|Dietary Supplement: Multivitamin|Dietary Supplement: Soy isoflavoneshttps://ClinicalTrials.gov/show/NCT00042731
191376191376A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.CompletedNo Results AvailableBronchitis|Chronic BronchitisDrug: levofloxacin, azithromycin, amoxicillin/clavulanatehttps://ClinicalTrials.gov/show/NCT00042718
191377191377Asthma Severity in Children and Environmental AgentsCompletedNo Results AvailableAsthmahttps://ClinicalTrials.gov/show/NCT00042705
191378191378Catechol Thioethers in Parkinson's DiseaseCompletedNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT00042692
191379191379A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.CompletedNo Results AvailableCarcinoma, Non-Small-Cell Lung|Pulmonary Neoplasms|Neoplasms, LungDrug: Gemcitabine|Drug: Carboplatin|Drug: LY900003https://ClinicalTrials.gov/show/NCT00042679
191380191380A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.CompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: LY317615https://ClinicalTrials.gov/show/NCT00042666
191381191381A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on DialysisCompletedNo Results AvailableSecondary Hyperparathyroidism|End Stage Renal DiseaseDrug: Placebo|Drug: AMG 073https://ClinicalTrials.gov/show/NCT00042653
191382191382Prevalence and Risk of Cataracts in Granulocyte DonorsCompletedNo Results AvailableApheresishttps://ClinicalTrials.gov/show/NCT00042627
191383191383Study of Heart Transplant RejectionRecruitingNo Results AvailableHeart Transplantationhttps://ClinicalTrials.gov/show/NCT00042614
191384191384Evaluation of the Effect of Pramlintide on Satiety and Food IntakeCompletedNo Results AvailableDiabetes Mellitus, Type 1|Diabetes Mellitus, Type 2Drug: Pramlintide acetatehttps://ClinicalTrials.gov/show/NCT00042601
191385191385A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and SepsisCompletedNo Results AvailablePneumonia|SepsisDrug: Recombinant Chimeric Monoclonal Antibodyhttps://ClinicalTrials.gov/show/NCT00042588
191386191386Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCompletedNo Results AvailableMajor Depressive DisorderDrug: Duloxetinehttps://ClinicalTrials.gov/show/NCT00042575
191387191387Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCompletedNo Results AvailableMajor Depressive DisorderDrug: duloxetinehttps://ClinicalTrials.gov/show/NCT00042562
191388191388Lithotripsy for the Treatment of GallstonesTerminatedNo Results AvailableCholelithiasisDevice: Extracorporeal Shock Wave Lithotripsy|Drug: ursodiolhttps://ClinicalTrials.gov/show/NCT00042549
191389191389Effects of Yohimbine and Naltrexone on Sexual FunctionCompletedNo Results AvailableErectile DysfunctionDrug: Naltrexone HCL/ Yohimbine HCLhttps://ClinicalTrials.gov/show/NCT00042536
191390191390Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusCompletedNo Results AvailableSystemic Lupus Erythematosushttps://ClinicalTrials.gov/show/NCT00042523
191391191391Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal CancerCompletedNo Results AvailableStomach Neoplasms|Esophageal NeoplasmsBiological: Treatment grouphttps://ClinicalTrials.gov/show/NCT00042510
191392191392Immunotherapy With Autologous Dexosomes for Patients With Stage IV MelanomaSuspendedNo Results AvailableMelanomaBiological: autologous dexosomes loaded with tumor-specific peptideshttps://ClinicalTrials.gov/show/NCT00042497
191393191393Community Organizing Network for Environmental HealthCompletedNo Results AvailableAsthmaProcedure: Community-level intervention & policy changehttps://ClinicalTrials.gov/show/NCT00042484
191394191394Evaluation of the Bioavailability of PramlintideCompletedNo Results AvailableDiabetes Mellitus, Type 1|Diabetes Mellitus, Type 2Drug: Pramlintide acetatehttps://ClinicalTrials.gov/show/NCT00042471
191395191395Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose ControlCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Pramlintide acetate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00042458
191396191396Brain Neoplasms, Leukemia and Petrochemical ExposuresCompletedNo Results AvailableLeukemia|Brain Neoplasmhttps://ClinicalTrials.gov/show/NCT00042445
191397191397Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency PatientsCompletedHas ResultsSecondary Hyperparathyroidism|Chronic Renal InsufficiencyDrug: cinacalcet (AMG 073)https://ClinicalTrials.gov/show/NCT00042432
191398191398Work and Health Disparities Among Rural WomenCompletedNo Results AvailableTendonitis|Carpal Tunnel Syndrome|Cumulative Trauma Disorders|Overuse Syndromehttps://ClinicalTrials.gov/show/NCT00042419
191399191399Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-alpha BlockerTerminatedNo Results AvailableRheumatoid ArthritisDrug: HuMax-CD4https://ClinicalTrials.gov/show/NCT00042406
191400191400An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment OptionsApproved for marketingNo Results AvailableChronic Hepatitis BDrug: Adefovir Dipivoxilhttps://ClinicalTrials.gov/show/NCT00042393

* Görseller ve İçerik tekif hakkına sahip olabilir